BONE-MARROW TRANSPLANTATION IN RAMATHIBODI-HOSPITAL - PROGRESS REPORT

Bone marrow transplantation has become the accepted treatment for seve ral hematologic disorders. We have done 3 autologous and 6 allogeneic bone marrow transplantations at Ramathibodi Hospital since July 1989 i n patients with acute lymphoblastic leukemia, acute non-lymphocytic le ukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma and severe ap lastic anemia. Only one patient with aplastic anemia had late graft re jection, but the rest of them engrafted and did well during the median follow up period of 317 days (range: 39 to 962 days) post transplanta tion. None of the allogeneic BMT had graft-versus-host disease. We use cyclosporin and short course methotrexate for post transplantation im munosuppression.